GENEVA, June 2 -- ETHERNA IMMUNOTHERAPIES NV (Galileilaan 192845 Niel) filed a patent application (PCT/EP2024/083493) for "METHOD FOR REDUCING DSRNA FORMATION DURING IVT" on Nov 25, 2024. With publication no. WO/2025/109225, the details related to the patent application was published on May 30, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): BAUER, Lubos (Galileilaan 192845 Niel), ASCI, Sinem Demirel (Galileilaan 192845 Niel), DILLEN, Senne (Galileilaan 192845 Niel), HEIRMAN, Carlo (Galileilaan 192845 Niel)
Abstract:
The invention relates to a method for reducing double stranded RNA (dsRN...